Bayer Cropscience balance sheet

As of Mar 2026

Total assets: ₹5,699cr+8.6% on Mar 2025
Shareholders' equity: ₹2,966cr+4.0% on Mar 2025
Cash and investments: ₹1,472cr+59.8% on Mar 2025
Cash from operations: ₹1,079crNo figure a year before

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	402	427	376	428
	—	—	—	2.9
	24.1	24.6	25.1	25.6
	32.8	18.2	13.2	—
	123	118	112	106
	—	129	151	177
	12.4	9.7	—	0.0
	47.2	42.1	—	—
	781	774	692	782
	2,136	2,362	1,545	1,807
	57.4	35.4	53.9	41.1
	1,116	952	960	976
	1,415	886	1,157	861
	12.2	—	174	—
	2,600	1,873	2,345	—
	176	221	—	—
	4,918	4,472	3,906	3,896
	5,699	5,246	4,597	4,679
Equity
	44.9	44.9	44.9	44.9
	2,921	2,806	2,805	2,667
	2,966	2,850	2,849	2,712
	2,966	2,850	2,849	2,712
Liabilities
	127	110	125	152
	—	0.0	—	0.9
	166	172	150	189
	1,238	1,098	605	873
	133	62.3	48.6	44.4
	102	87.1	51.8	113
	1,047	931	—	—
	2,568	2,224	1,597	1,778
	2,734	2,396	1,748	1,967
	5,699	5,246	4,597	4,679

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

BAYERCROP₹3,289.80

Bayer Cropscience Ltd.

· Chemicals

₹ CrorePeersUPL PIIND RALLIS ATUL SHK ANURAS CAMLINFINE CLEAN

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	428.4	376.2	426.9	401.5
+ Capital Work-in-Progress	2.9	—	—	—
+ Investment Property	25.6	25.1	24.6	24.1
+ Other Intangibles	—	13.2	18.2	32.8
+ Intangibles under Development	106.3	112.2	118.2	122.5
+ Other Non-current Financial Assets	176.8	151.3	129.3	—
+ Deferred Tax Assets	0.0	—	9.7	12.4
+ Other Non-current Assets	—	—	42.1	47.2
Total Non-current Assets	782.2	691.6	774.3	781.1
Current Assets
+ Inventories	1,807.2	1,545.2	2,361.8	2,135.5
+ Current Investments	41.1	53.9	35.4	57.4
+ Trade Receivables	975.6	960.1	952.1	1,115.5
+ Cash & Cash Equivalents	860.8	1,156.8	885.5	1,414.6
+ Other Current Financial Assets	—	174.3	—	12.2
Current Financial Assets	—	2,345.1	1,873.0	2,599.7
+ Other Current Assets	—	—	220.9	175.9
Total Current Assets	3,896.4	3,905.5	4,471.6	4,918.3
Total Assets	4,678.6	4,597.1	5,245.9	5,699.4
Equity
+ Equity Share Capital	44.9	44.9	44.9	44.9
+ Other Equity / Reserves	2,667.2	2,804.5	2,805.5	2,920.8
Equity — Owners of Parent	2,712.1	2,849.4	2,850.4	2,965.7
Total Equity	2,712.1	2,849.4	2,850.4	2,965.7
Liabilities
+ Provisions — Non-current	152.3	125.3	110.2	127.4
+ Deferred Tax Liabilities	0.9	—	0.0	—
Non-current Liabilities	189.0	150.3	171.8	166.2
+ Trade Payables	873.2	605.1	1,098.4	1,237.9
+ Other Current Financial Liab	44.4	48.6	62.3	133.2
+ Provisions — Current	113.0	51.8	87.1	101.9
+ Other Current Liabilities	—	—	930.7	1,047.0
Current Liabilities	1,777.5	1,597.4	2,223.7	2,567.5
Total Liabilities	1,966.5	1,747.7	2,395.5	2,733.7
Total Equity & Liabilities	4,678.6	4,597.1	5,245.9	5,699.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.